Summary: The Case for QALY's: US Decision-
Making for Pharmaceuticals
Sr. Director Pharmacoeconomics
What's wrong with QALYs, they seem so nice?
Apologies to R. Townsend
& Koala Bears
What's Wrong with QALY's - Common Criticisms
Historically cost-utility analysis was used to value
programs with widely different outcomes often mis-
Whose preferences should be used?
Can the stages of disease be adequately depicted so
utilities can be determined? Measurement is
May not ethically distribute healthcare often left with
discussing appropriate thresholds